| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
• Seneca Biopharma, Inc. (NASDAQ:SNCA) shares moved upwards by 27.78% to $1.05 during Thursday's pre-market session.
• Aurora Cannabis, Inc. (NYSE:ACB) shares increased by 25.80% to $16.04. The most recent rating by Piper Sandler, on May 15, is at Neutral, with a price target of $10.
• IMV, Inc. (NASDAQ:IMV) shares increased by 20.48% to $4. The most recent rating by Wells Fargo, on May 18, is at Overweight, with a price target of $8.
• Alterity Therapeutics, Inc. (NASDAQ:ATHE) shares rose 10.75% to $0.72.
• Aquestive Therapeutics, Inc. (NASDAQ:AQST) stock moved upwards by 5.99% to $6.55.
• Guardion Health Sciences, Inc. (NASDAQ:GHSI) stock moved upwards by 5.75% to $0.52.
• Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) stock moved upwards by 5.26% to $4.60. The most recent rating by Oppenheimer, on May 12, is at Outperform, with a price target of $12.
• Altimmune, Inc. (NASDAQ:ALT) stock rose 4.95% to $6.36.
• HEXO, Inc. (NYSE:HEXO) stock moved upwards by 4.66% to $0.51. The most recent rating by Roth Capital, on Mar 31, is at Neutral, with a price target of $1.
• Midatech Pharma, Inc. (NASDAQ:MTP) shares moved upwards by 4.61% to $1.59.
• Akorn, Inc. (NASDAQ:AKRX) stock declined 24.97% to $0.21 during Thursday's pre-market session.
• scPharmaceuticals, Inc. (NASDAQ:SCPH) shares fell 17.82% to $8.90. The most recent rating by HC Wainwright & Co., on May 13, is at Buy, with a price target of $15.
• Synlogic, Inc. (NASDAQ:SYBX) stock decreased by 10.29% to $2.18.
• Flexion Therapeutics, Inc. (NASDAQ:FLXN) shares decreased by 9.80% to $9.85. The most recent rating by Needham, on May 8, is at Buy, with a price target of $20.
• Entera Bio, Inc. (NASDAQ:ENTX) shares fell 8.77% to $2.60.
• Surface Oncology, Inc. (NASDAQ:SURF) shares fell 8.51% to $3.55.
• Miragen Therapeutics, Inc. (NASDAQ:MGEN) shares fell 8.30% to $0.58.
• Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) shares decreased by 7.41% to $3. The most recent rating by Aegis Capital, on Apr 13, is at Buy, with a price target of $15.
• DBV Technologies, Inc. (NASDAQ:DBVT) shares fell 6.53% to $4.58. The most recent rating by Citigroup, on Apr 6, is at Buy, with a price target of $10.
• Galapagos, Inc. (NASDAQ:GLPG) stock fell 6.01% to $207.98. The most recent rating by Morgan Stanley, on Apr 15, is at Equal-Weight, with a price target of $226.
Posted In: ACB AKRX ALDX ALT AQST ATHE DBVT EKSO ENTX FLXN GHSI GLPG HEXO IMV MGEN MTP SCPH SNCA SURF SYBX
